[1]
J. G. Grohs, M. Schmidt, and A. Wanivenhaus, “Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up”, ActaO, vol. 78, no. 1, pp. 95–98, Jan. 2007.